Value Research Rating

2 star

Quality Score fund-quick-summary-circle

Quality Score0/0

Growth Score fund-quick-summary-circle

Growth Score0/0

Valuation Score fund-quick-summary-circle

Valuation Score0/0

Momentum Score fund-quick-summary-circle

Momentum Score0/0

Piramal Pharma Ltd. Share Price

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range
Low: 181.73 High: 201.85
52 Week Range
Low: 114.35 High: 307.90
Liquidityliquidity High
Low Moderate High

Fundamentals

  • Market capMarket cap information

    ₹24,500 Cr

  • P/E RatioP/E Ratio information

    629.82

  • P/B RatioP/B Ratio information

    3.1

  • Industry P/EIndustry P/E information

    37.17

  • Debt to EquityDebt to Equity information

    0.58

  • ROEROE information

    0.24 %

  • ROCEROCE information

    5.07 %

  • Div. YieldDiv. Yield information

    0.06 %

  • Book ValueBook Value information

    59.56

  • EPSEPS information

    0.4

10 Years Aggregate

CFO

₹--

EBITDA

₹--

Net Profit

₹--

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Piramal Pharma
-30.55 -20.52 -28.80 37.22 -- -- --
BSE Healthcare
-11.69 -6.28 -6.00 12.99 17.86 22.52 9.66
BSE Mid Cap
-14.35 -6.28 -9.92 2.49 17.89 20.27 13.97
As on 14-Feb-2025
2024
2023
Piramal Pharma
92.17 24.01
BSE Mid Cap
25.84 45.53
BSE Healthcare
43.09 36.97

Essential Checks View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials Detailed View

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios view all

loading...

loading...

loading...

3Y Avg -- 5Y Avg -- TTM --

loading...
P/E Ratio

--

--Min --Median --Max

loading...
P/B Ratio

--

--Min --Median --Max

loading...
Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peer view all

Company
Price (₹) Market Cap (₹ Cr) P/E Ratio ROE
1,323.05 37,286.93 -- -15.04
546.20 29,472.84 147.17 4.86
1,089.65 27,701.76 99.21 13.86
690.35 27,803.23 55.44 11.04

Shareholding Pattern Detailed Holdings

loading...
BLAHBLAH

News & Analysis All News

About The Company

Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India....  Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.  Read more

  • Incorporated

    2020

  • Chairman

    Nandini Piramal

  • Managing Director

    --

  • Headquarters

    Mumbai, Maharashtra

  • Website

    www.piramalpharma.com

Edit peer-selector-edit
loading...
loading...
loading...
loading...

FAQs for Piramal Pharma Ltd.

The total asset value of Piramal Pharma Ltd stood at ₹ 15,242 Cr as on 31-Dec-24

The share price of Piramal Pharma Ltd is ₹184.90 (NSE) and ₹184.80 (BSE) as of 14-Feb-2025 IST. Piramal Pharma Ltd has given a return of 37.22% in the last 1 years.

Piramal Pharma Ltd has a market capitalisation of ₹ 24,500 Cr as on 14-Feb-2025. As per Value Research classification, it is a Mid Cap company.

The P/B ratio of Piramal Pharma Ltd is 3.10 times as on 14-Feb-2025, a 11% discount to its peers’ median range of 3.48 times.

The P/E ratio of Piramal Pharma Ltd is 629.82 times as on 14-Feb-2025, a 1594% premium to its peers’ median range of 37.17 times.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Piramal Pharma Ltd and enter the required number of quantities and click on buy to purchase the shares of Piramal Pharma Ltd.

Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.

The prominent promoters of Piramal Pharma Ltd. are

Name of promoters Holding percentage

The Sri Krishna Trust through its Trustee Mr. Ajay G Piramal and Dr. (Mrs.) Swati A Piramal

26.62%

V3 Designs LLP

3.25%

PRL Realtors LLP

3%
Click here to see the full list

The chairman of the company is Nandini Piramal, and the managing director is .

There is no promoter pledging in Piramal Pharma Ltd.

Some of the close peers are:

Company Market Cap(₹ Cr)
37,287
29,473
27,803
27,702
Piramal Pharma Ltd. Ratios
Return on equity(%)
0.67
Operating margin(%)
7.2
Net Margin(%)
-0.33
Dividend yield(%)
0.06

Yes, TTM profit after tax of Piramal Pharma Ltd was ₹39 Cr.